GCGR and type 2 diabetes mellitus: Strikingly, mice deleted for glucagon receptors fail to develop hyperglycemia after the destruction of the β-cell complement (5), demonstrating the likely importance of maintained or increased glucagon signaling in the context of type 2 diabetes (T2D)4 (6, 7).